FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Apotex Enalapril maleate and hydrochlorothiazide Recall

Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx o…

Apotex Inc. · Toronto, N/A

Risk level
Class II
Reported by FDA
Jul 15, 2015
Recall ID
D-1215-2015
Check your lot numberHow we source this data

Summary

Apotex recalled Enalapril maleate and hydrochlorothiazide starting May 29, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1215-2015 on Jul 15, 2015. Reason: Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification. Status: Terminated.

Why it was recalled

Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.

Product description

Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India, NDC 60505-0209-1

Lot numbers, UPCs & expiration codes

Lot #: KP4529, Exp 10/2015

Where it was sold

Nationwide, Hawaii and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1215-2015
Classification
Class II
Status
Terminated
Recall initiated
May 29, 2015
FDA report date
Jul 15, 2015
Quantity
4,584 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Inc.

Original FDA data

Every field from FDA enforcement report D-1215-2015, exactly as published.

Show all FDA fields
City
Toronto
Status
Terminated
Country
Canada
Event ID
71418
Address
150 Signet Drive
Code information
Lot #: KP4529, Exp 10/2015
Report date
Jul 15, 2015
Product type
Drugs
Recall number
D-1215-2015
Classification
Class II
Recalling firm
Apotex Inc.
Product quantity
4,584 bottles
Termination date
Mar 3, 2017
Reason for recall
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India, NDC 60505-0209-1
Distribution pattern
Nationwide, Hawaii and Puerto Rico
Recall initiation date
May 29, 2015
Initial firm notification
Letter
Center classification date
Jul 7, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1215-2015, published Jul 15, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls